Threading the needle of using gender-inclusive language (failing to do so contributes to trans people not seeking care) while still acknowledging that there are phenotypical differences between the sexes is a challenge. Some people do indeed go too far in the inclusivity direction. Part of the problem is that we haven't done enough studies, both because of stigma and because of the unavoidably small sample size, on trans people who have medically transitioned. Does the risk of long COVID decrease for a trans man who has been on testosterone for a few years? We don't know and it's hard to find out.

In some ways we need to separate discussion of reproductive biology for medical reasons from discussion of gender. Unfortunately, this does lead to some awkward constructs. But, again, not doing so discourages trans people from seeking care, which is a big problem. Especially right now.